In This Issue
10-Year APBI Data: Equivalent Outcomes, Better Cosmesis
Lit Review: APBI vs. WBI
SAVI Available in Japan
BrachyBytes Editorial Advisory Board

Robert Kuske, M.D.

Jay Reiff, Ph.D.
Dan Scanderbeg, Ph.D.
Catheryn Yashar, M.D.
Vic Zannis, M.D.
Upcoming Events


San Antonio Breast Cancer Symposium
December 10-14, 2013

Henry B. Gonzalez Convention Center
San Antonio, TX

Become a Center of Excellence in APBI

Learn about becoming a Center of Excellence and find ways to grow your APBI program by reaching out to referring physicians and women in the community.

Contact for more information.  
Follow-up Links

Past Issues
Cianna Medical

BEST Forum
SAVI Sisters

Central DuPage Hospital
Summa Health System
The BC5 Project

October 2013 

Hypofractionated WBI: Where Does it Fit in the Treatment Paradigm?  
Christy Kesslering, MD & Chirag Shah, MD   

In the past several years, randomized clinical trials in Canada and the United Kingdom have compared outcomes of hypofractionated whole breast irradiation (WBI) to conventional WBI. While the data show little difference in local control and survival, there is still disagreement as to whether more evidence is needed before the results can be applied to all patient subgroups.

Radiation oncologists Christy Kesslering, MD, Central DuPage Hospital, Warrenville, Ill., and Chirag Shah, MD, Summa Health System, Akron, Oh., share their views on the current data, how hypofractionated WBI fits into their treatment options, and why patients tend to prefer brachytherapy. Read more

Survey Finds Many Women Unaware of Treatment Options

An online survey of 100 women, age 50+ who have been treated for breast cancer, revealed that a majority of the women were unaware of all available treatment options, including brachytherapy. The results also highlight the significant impact physicians have on their patients’ decision-making process.

According to the survey,

  • After the doctor’s recommendation, effect of a treatment on one’s quality of life is most important, if not fully considered or discussed.
  • Of those for whom breast brachytherapy could have been an option, 76% say they would have been interested in learning more about the treatment.
  • The most important factor in selecting a treatment is a doctor’s recommendation.

“As physicians, we should strive to take on a more active role becoming aware of all the options ourselves, so we can better educate women and close this knowledge gap,” said Dr. Cathryn Yashar, Associate Professor of Radiation Oncology, the University of California San Diego. Read more

SAVI Breast Brachytherapy Available in Japan

Cianna Medical recently received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the SAVI® applicator in Japan. Cianna has partnered with MC Medical, Inc., a subsidiary of Mitsubishi Corporation, to bring SAVI to the Japanese healthcare market.

According to research, breast cancer rates in Japan will rise by an estimated 24% by 2019 to reach 57,000 women compared to 46,000 cases in 2010. SAVI’s strut-based design allows physicians to deliver customized radiation based on patient-specific anatomy. In Japan, where women have relatively smaller breasts, SAVI could make APBI available to a broader swath of patients. Read more